Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer. |
Synonyms | THA-Q, PD-139530, THA Q, PD 139530, PD139530 |
Molecular Weight | 214.26 |
Formula | C13H14N2O |
CAS No. | 4425-23-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RLX 4425-23-4 THA-Q PD-139530 THA Q PD 139530 PD139530 inhibitor inhibit